logo

For the Inventor, By the Inventor

Los Angeles, CA, United States of America

Shlomo Melmed

This inventor holds 21 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Cancer Biomarkers. Top assignee: Cedars-Sinai Medical Center. Active years: 1998-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shlomo Melmed. Retrieved from https://idiyas.com/inventor/shlomo-melmed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 52.4

 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 45(Granted Patents)


Company Filing History:

goldMedal21 out of 628 
 
Cedars-Sinai Medical Center
 patents

Years Active: 1998-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Cushing's Disease
PTTG Gene
Drug Screening
Calcium Flux
Cancer Treatment
Transgenic Cells
Biomarkers
Neoplastic Proliferation
Genetic Therapy
Pituitary Tumors
Insulin-like Growth Factor
Transgenic Models
21 patents (USPTO):Explore Patents
1. 9387211 - Methods for treatment of Cushing'S disease and hypercortisolism using gefitinib (2016-07-12),
2. 8709804 - Method for drug screening and characterization by calcium flux (2014-04-29),
3. 8216782 - PTTG1 as a biomarker for cancer treatment (2012-07-10),
4. 7097829 - Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses therefor (2006-08-29),
5. 6943018 - Transgenic expression from a SOCS-3 promoter in vertebrate cells (2005-09-13),
6. 6939544 - Antibodies against mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides (2005-09-06),
7. 6913926 - Method of regulating biological activity of pituitary tumor transforming gene (PTTG)1 using PTTG2 (2005-07-05),
8. 6911320 - Rat PTTG polypeptide and method for producing it (2005-06-28),
9. 6909030 - PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes (2005-06-21),
10. 6900032 - Human PTTG polypeptide and method for producing it (2005-05-31),
11. 6894031 - Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation (2005-05-17),
12. 6858586 - Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation (2005-02-22),
13. 6835380 - Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides (2004-12-28),
14. 6750327 - Compositions and method for determining the presence of human PTTG peptide in a sample (2004-06-15),
15. 6723519 - Compositions and method for determining the presence of rat PTTG peptide in a sample (2004-04-20),

Title: The Innovative Journey of Shlomo Melmed

Introduction: Shlomo Melmed is a renowned inventor based in Los Angeles, CA (US) known for his groundbreaking contributions to the field of medicine and healthcare.

Latest Patents: Shlomo Melmed holds several patents related to medical devices and treatment methods that have revolutionized the industry. His recent patents focus on innovative technologies for early disease detection and personalized medicine.

Career Highlights: With a distinguished career spanning several decades, Shlomo Melmed has held key positions in leading research institutions and universities. He has been instrumental in developing novel therapies for complex medical conditions, earning him international recognition.

Collaborations: Throughout his career, Shlomo Melmed has collaborated with top researchers, scientists, and healthcare professionals to bring cutting-edge solutions to the market. His collaborative efforts have resulted in the successful implementation of innovative medical technologies worldwide.

Conclusion: Shlomo Melmed's relentless pursuit of innovation and commitment to improving healthcare have solidified his reputation as a pioneering inventor in the field. His work continues to inspire future generations of inventors and researchers in the quest for transformative medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…